In case this article has not been posted yet......from Onclive's website (dated Aug. 28-15). A nice summary. Also, interesting to see it is currently tracking as their most read article. --- FDA Grants Intravesical Immunotherapy Priority Review for Bladder Cancer - See more at: https://www.onclive.com/web-exclusives/fda-grants-intravesical-immunotherapy-priority-review-for-bladder-cancer#sthash.PP96raZx.dpuf